MétaCan
Menu
Back to cohort
Record W4385409087 · doi:10.1093/ibd/izad134

Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn’s Disease Clinical Trials

2023· review· en· W4385409087 on OpenAlexaff
Eileen Crowley, Christopher Ma, Leonard Guizzetti, Guangyong Zou, Peter Lewindon, Michael S. Gee, Jeffrey S. Hyams, Michael J. Rosen, Daniel von Allmen, Anthony de Buck van Overstraeten, Lisa M. Shackelton, Julie Rémillard, Lauren S. Schleicher, Jonathan R. Dillman, Jordi Rimola, Stuart A. Taylor, Joel G. Fletcher, Peter Church, Brian G. Feagan, Anne M. Griffiths, Vipul Jairath, Mary‐Louise C. Greer

Bibliographic record

VenueInflammatory Bowel Diseases · 2023
Typereview
Languageen
FieldMedicine
TopicAnorectal Disease Treatments and Outcomes
Canadian institutionsHospital for Sick ChildrenUniversity of CalgarySickKids FoundationUniversity of TorontoLondon Health Sciences CentreMount Sinai HospitalWestern University
FundersAllerganSamsungGenentechSiemens HealthineersUCB PharmaBracco DiagnosticsAkebia TherapeuticsCelltrionMylanLeona M. and Harry B. Helmsley Charitable TrustAbbVieTeva Pharmaceutical IndustriesGilead SciencesSanofiCelgeneBiogenGlaxoSmithKlineTillotts PharmaAmgenPfizerAstraZenecaEli Lilly and CompanyBristol-Myers Squibb
KeywordsMedicineMagnetic resonance imagingDiseaseClinical trialFistulaRadiologyCrohn's diseaseInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Perianal fistulas and abscesses occur commonly as complications of pediatric Crohn's disease (CD). A validated imaging assessment tool for quantification of perianal disease severity and activity is needed to evaluate treatment response. We aimed to identify magnetic resonance imaging (MRI)-based measures of perianal fistulizing disease activity and study design features appropriate for pediatric patients. METHODS: Seventy-nine statements relevant to MRI-based assessment of pediatric perianal fistulizing CD activity and clinical trial design were generated from literature review and expert opinion. Statement appropriateness was rated by a panel (N = 15) of gastroenterologists, radiologists, and surgeons using modified RAND/University of California Los Angeles appropriateness methodology. RESULTS: The modified Van Assche Index (mVAI) and the Magnetic Resonance Novel Index for Fistula Imaging in CD (MAGNIFI-CD) were considered appropriate instruments for use in pediatric perianal fistulizing disease clinical trials. Although there was concern regarding the use of intravascular contrast material in pediatric patients, its use in clinical trials was considered appropriate. A clinically evident fistula tract and radiologic disease defined as at least 1 fistula or abscess on pelvic MRI were considered appropriate trial inclusion criteria. A coprimary clinical and radiologic end point and inclusion of a patient-reported outcome were also considered appropriate. CONCLUSION: Outcomes of treatment of perianal fistulizing disease in children must include MRI. Existing multi-item measures, specifically the mVAI and MAGNIFI-CD, can be adapted and used for children. Further research to assess the operating properties of the indices when used in a pediatric patient population is ongoing.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.599
metaresearch head score (Gemma)0.759
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: Methods
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.401
Threshold uncertainty score0.494

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.5990.759
Meta-epidemiology (narrow)0.0040.004
Meta-epidemiology (broad)0.0080.014
Bibliometrics0.0140.016
Science and technology studies0.0040.007
Scholarly communication0.0170.012
Open science0.0130.007
Research integrity0.0240.026
Insufficient payload (model declined to judge)0.0050.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.299
GPT teacher head0.520
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
DomainMethods
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueInflammatory Bowel DiseasesSame topicAnorectal Disease Treatments and OutcomesFrench-language works237,207